The effect of fascin 1 inhibition on head and neck squamous cell carcinoma cells
Authors:
- Awais WahabAWAwais Wahab
- Aini HyytiäinenAHAini Hyytiäinen
- Wafa WahbiWWWafa Wahbi
- Katja TuomainenKTKatja Tuomainen
- Sanni TervoSTSanni Tervo
- Pablo Conesa‐ZamoraPCPablo Conesa‐Zamora
- Laura JauhiainenLJLaura Jauhiainen
- Laura K. MäkinenLMLaura K. Mäkinen
- Timo PaavonenTPTimo Paavonen
- Sanna Toppila‐SalmiSTSanna Toppila‐Salmi
- Abdelhakim SalemAbdelhakim Salem
- Alhadi AlmangushAAAlhadi Almangush
Open Access
- 4 August 2021
- journal article
- research article
- Published by Wiley in European Journal of Oral Sciences
- Vol. 129 (6) , e12819
Abstract
Fascin 1 plays important pro‐metastatic roles in head and neck carcinoma (HNSCC) migration, invasion, and metastasis. However, limited advancement in targeting metastasis remains a major obstacle in improving HNSCC patients’ survival. Therefore, we assessed the therapeutic potential of fascin 1 targeted inhibition and its potential prognostic value in HNSCC patients. Using in vitro and in vivo approaches, we investigated the effect of compound G2, a novel fascin 1 inhibitor, on HNSCC cells migration, invasion, and metastasis. High‐throughput screening (HTS) was used to assess cytotoxic activity of compound G2 alone or combined with irradiation. We also evaluated the prognostic potential of fascin 1 in HNSCC patients. Interestingly, compound G2 reduced carcinoma cells migration and invasion in vitro and inhibited metastasis in vivo. Moreover, HTS revealed a modest cytotoxic activity of the compound G2 on HNSCC cell lines. Irradiation did not synergistically enhance the compound G2‐mediated cytotoxic activity. Survival analyses showed that high fascin 1 immunoexpression, at the tumor invasive front, was associated with cancer‐specific mortality in the advanced stages of HNSCC. Collectively, our findings suggest that fascin 1 represents a promising anti‐metastatic therapeutic target and a useful prognostic marker in patients with HNSCC. Novel anti‐metastatic agents could provide a valuable addition to cancer therapy.Keywords
This publication has 34 references indexed in Scilit:
- Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysisBMC Medicine, 2013
- Molecular Mechanism of Fascin Function in Filopodial FormationJournal of Biological Chemistry, 2013
- Fascin expression is related to poor survival in gastric cancerPathology International, 2012
- The roles of fascins in health and diseaseThe Journal of Pathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- FascinCommunicative & Integrative Biology, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate CancerClinical Cancer Research, 2009
- Fascin over-expression is associated with aggressiveness of oral squamous cell carcinomaCancer Letters, 2007
- Prognostic Significance of Fascin Overexpression in Human Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2005